NCT03068546

Brief Summary

Background: The human biome is the collection of microbial genes found in and on the body. It has been associated with many health conditions. But certain factors might affect the findings from microbiome studies. These include collection method, lab handling, and data processing. Researchers want to test the effect of long-term storage in a freezer on two oral sample collections methods. These methods are OMNIgene ORAL and Scope mouthwash. Objective: To test the effect of long-term freezing on the oral microbiome measured from OMNIgene ORAL and Scope mouthwash. Eligibility: Employees of the National Cancer Institute who:

  • Are age 18 or older
  • Have not used antibiotics in the past 3 months Design: Participants will have 6 visits within 2 weeks. At visit 1 they will complete a questionnaire about health and lifestyle. All visits last 15-30 minutes and include:
  • 1-2 saliva samples using OMNIgene ORAL: They will spit in a collector.
  • 1-2 Scope samples: They will gargle with Scope mouthwash and spit in a cup.
  • Questions about how well they followed the preparation procedures Participants will follow preparation procedures: For 12 hours before each visit, they must not:
  • Brush their teeth
  • Floss
  • Use mouthwash
  • Eat or drink anything other than water
  • Chew gum
  • Consume throat lozenges or candies
  • Smoke or chew tobacco Participants samples will be stored in a freezer. They will get data about their oral microbiome if they wish.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 28, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 3, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

June 29, 2017

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 22, 2019

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2019

Completed
Last Updated

December 16, 2020

Status Verified

December 1, 2020

Enrollment Period

1.6 years

First QC Date

February 28, 2017

Last Update Submit

December 11, 2020

Conditions

Keywords

Oral Microbiota

Outcome Measures

Primary Outcomes (1)

  • Oral microbiome characteristics

    Microbial community characteristics

    One month after recruitment

Secondary Outcomes (1)

  • Stability of oral microbiome characteristics

    One year after recruitment

Study Arms (1)

Participants providing samples

NCI employees agreeing to provide samples for microbiome sample study

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Employees of National Cancer Institute

* ELIGIBILITY: Anyone working at the NCI is eligible. Children (\<18 years of age) will not be included since children do not work for NCI and followup would be more difficult. People of any age (adult), race, gender, or other factor are invited to participate. No competent adult volunteers will be excluded. The only exclusion of adults will be if the participant has taken antibiotic medication in the prior 3 months since antibiotic use has been shown to disrupt the oral microbiome, although less so than the fecal microbiome.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

National Cancer Institute (NCI)

Bethesda, Maryland, 20892, United States

Location

Related Publications (3)

  • Carroll IM, Ringel-Kulka T, Siddle JP, Klaenhammer TR, Ringel Y. Characterization of the fecal microbiota using high-throughput sequencing reveals a stable microbial community during storage. PLoS One. 2012;7(10):e46953. doi: 10.1371/journal.pone.0046953. Epub 2012 Oct 5.

    PMID: 23071673BACKGROUND
  • Vogtmann E, Goedert JJ. Epidemiologic studies of the human microbiome and cancer. Br J Cancer. 2016 Feb 2;114(3):237-42. doi: 10.1038/bjc.2015.465. Epub 2016 Jan 5.

    PMID: 26730578BACKGROUND
  • Zaura E, Brandt BW, Teixeira de Mattos MJ, Buijs MJ, Caspers MP, Rashid MU, Weintraub A, Nord CE, Savell A, Hu Y, Coates AR, Hubank M, Spratt DA, Wilson M, Keijser BJ, Crielaard W. Same Exposure but Two Radically Different Responses to Antibiotics: Resilience of the Salivary Microbiome versus Long-Term Microbial Shifts in Feces. mBio. 2015 Nov 10;6(6):e01693-15. doi: 10.1128/mBio.01693-15.

    PMID: 26556275BACKGROUND

Study Officials

  • Christian Abnet, Ph.D.

    National Cancer Institute (NCI)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 28, 2017

First Posted

March 3, 2017

Study Start

June 29, 2017

Primary Completion

January 22, 2019

Study Completion

December 20, 2019

Last Updated

December 16, 2020

Record last verified: 2020-12

Locations